A case report on the use of sustained release platelet-rich plasma for the treatment of chronic pressure ulcers

Journal of Spinal Cord Medicine

Volumn 34, Issue 1, 2011, Pages 122-127

  Sell, Scott A ^a,b   Ericksen, Jeffery J ^a,c   Reis, Timothy W ^a,c   Droste, Linda R ^a   Bhuiyan, Mohammed B A ^a   Gater, David R ^a,c  

^a HUNTER HOLMES MCGUIRE VA MEDICAL CENTER   (United States)

^b Virginia Commonwealth University   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Paraplegia; Platelet rich plasma therapy; Pressure ulcers; Spinal cord injuries; Tetraplegia; Wound healing

Indexed keywords

ALGINIC ACID; CALCIUM CHLORIDE; HYPOCHLORITE SODIUM; TESTOSTERONE;

ADULT; ALLOGRAFT; ARTICLE; CASE REPORT; CHRONIC DISEASE; DEBRIDEMENT; DECUBITUS; DISEASE SEVERITY; GRANULATION TISSUE; HUMAN; HYPOGONADISM; MALE; QUADRIPLEGIA; SPINAL CORD INJURY; SUSTAINED RELEASE FORMULATION; THROMBOCYTE RICH PLASMA; VASCULARIZATION; VETERAN; WOUND HEALING; WOUND IRRIGATION; COMPLICATION; MIDDLE AGED; PRESSURE ULCER;

ADULT; CHRONIC DISEASE; HUMANS; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; PRESSURE ULCER; QUADRIPLEGIA; SPINAL CORD INJURIES; WOUND HEALING;

EID: 79953053085     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1179/107902610X12923394765616     Document Type: Article

References (23)

1. Pressure ulcer prevention and treatment following spinal cord injury: a clinical practice guideline for health-care professionals. The Consortium of Spinal Cord Medicine, ed. Paralyzed Veterans of America, 2000:80.
2. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004;9:283-9. (Pubitemid 38925460)
3. Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil 2005;26(4):306-19.
4. Garber SL, Rintala DH. Pressure ulcers in veterans with spinal cord injury: a retrospective study. J Rehabil Res Dev 2003;40(5):433-41.
5. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, et al. Platelet-rich plasma: growth factors and pro- and antiinflammatory properties. J Periodontal 2007;78(4):661-9.
6. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009;37(11):2259-72.
7. Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat 2007;16(4):156-65.
8. Everts PA, Knape JT, Weibrich G, et al. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol 2006;38(2):174-87. (Pubitemid 351506605)
9. Sanchez M, Anitua E, Orive G, Mujika I, Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39(5):345-54.
10. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med. 2008;42:314-20. (Pubitemid 351702675)
11. Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 2009;91(8):987-96.
12. Anitua E, Sanchez M, Orive G, Andia I. Delivering growth factors for therapeutics. Trends Pharmacol Sci 2008;29(1):37-41.
13. Lyras DN, Kazakos K, Verettas D, et al. The effect of platelet-rich plasma gel in the early phase of patellar tendon healing. Arch Orthop Trauma Surg. 2009;129(11):1577-82.
14. Murray MM, Spindler KP, Abreu E, et al. Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament. J Orthop Res 2007;25:81-91. (Pubitemid 46070734)
15. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006;34(11):1774-8. (Pubitemid 44735517)
16. Anitua E, Aguirre JJ, Algorta J, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B 2008;84(2):415-21.
17. Kocaoemer A, Kern S, Kluter H, Bieback K., Human AB. Serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007;25(5):1270-8. (Pubitemid 46684887)
18. Lu HH, Vo JM, Chin HS, et al. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J Biomed Mater Res A 2008;86(4):1128-36.
19. Wang N, Adams G, Buttery L, Falcone FH, Stolnik S. Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J Biotechnol 2009;144(4): 304-12.
20. Zimmermann H, Zimmermann D, Reuss R, et al. Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J Mater Sci Mater Med 2005;16(6):491-501. (Pubitemid 40884240)
21. Shakoor SK, Aldibbiat A, Ingoe LE, et al. Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. J Clin Endocrinol Metab 2010;95(1):319-22.
22. Fadini GP, Coracina A, Baesso I, et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 2006;37(9):2277-82. (Pubitemid 44337169)
23. Dome P, Teleki Z, Rihmer Z, et al. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psychiatry 2009;14(5):523-31.